Statistics for TRIB2 confers resistance to MAPK and TOR1 inhibitors
Total visits
| views | |
|---|---|
| TRIB2 confers resistance to MAPK and TOR1 inhibitors | 121 |
Total visits per month
| views | |
|---|---|
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
File Visits
| views | |
|---|---|
| Tese_Neuton.pdf | 208 |
Top country views
| views | |
|---|---|
| Portugal | 48 |
| United States | 24 |
| China | 20 |
| Germany | 4 |
| Denmark | 4 |
| Spain | 3 |
| Turkey | 2 |
| Finland | 1 |
| France | 1 |
| United Kingdom | 1 |
| Croatia | 1 |
| Iran | 1 |
| South Korea | 1 |
| Nigeria | 1 |
| New Zealand | 1 |
| Poland | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Warsaw | 1 |